MetaCap

MindWalk (HYFT) vs XBiotech (XBIT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

XBiotech (XBIT) has outperformed MindWalk (HYFT) over the past year, losing 18.2% versus a loss of 20.2%. Over five years, HYFT leads with a -77.2% price change compared with -83.3% for XBIT. MindWalk is the larger company by market cap ($67.4 million vs $67.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HYFT-20.21%XBIT-17.05%
+53%+1%-50%
Oct 7, 20251 yearOct 7, 2026
HYFT-75.29%XBIT-83.01%
+29%-36%-100%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HYFT versus XBIT key metrics
MetricHYFTXBIT
Share price$1.43$2.20
Market cap$67.37M$67.07M
1-day change-4.67%+0.46%
YTD return-17.58%-7.95%
1-year return-20.21%-18.22%
5-year return-77.20%-83.35%
Forward P/E—16.92
EPS (TTM)$-0.26$-1.48
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.99$3.44
52-week low$0.99$2.09
Distance from 52-week high-52.17%-36.05%
Analyst consensusnone—
Avg. price target upside+202.80%—
Average volume225.20K40.47K
Shares outstanding47.11M30.49M
Employees7487
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About MindWalk

HYFT stock →

MindWalk Holdings Corp. operates as a bio-native AI company.

Healthcare · Biotechnology · 74 employees

About XBiotech

XBIT stock →

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.

Healthcare · Biotechnology · 87 employees

HYFT vs XBIT FAQ

Which is bigger, MindWalk or XBiotech?

MindWalk (HYFT) is larger, with a market capitalization of $67.37M compared with $67.07M for XBiotech (XBIT).

Which stock has performed better over the past year, HYFT or XBIT?

XBIT returned -18.22% over the past 12 months, compared with -20.21% for HYFT (price return, excluding dividends). Past performance does not predict future results.

Are MindWalk and XBiotech in the same industry?

Yes. Both are classified in the Biotechnology industry within the Healthcare sector.

More comparisons